Skip to main content
Top

Breast Cancer Research and Treatment

Issue 2/1999

Content (13 Articles)

Sentinel lymphadenectomy in breast cancer: identification of sentinel lymph node and detection of metastases

Masakuni Noguchi, Koichiro Tsugawa, Etsuro Bando, Futoshi Kawahara, Koichi Miwa, Kunihiko Yokoyama, Ken-ichi Nakajima, Norihisa Tonami

Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)

Oscar Juan, Ana Lluch, Laura de Paz, Felipe Prósper, Pilar Azagra, Isabel Marugán, Angel Martínez-agulló, Javier Garcia-conde

Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo

Kozo Koshizuka, Michiaki Koike, Hiroya Asou, Steve K. Cho, Tony Stephen, Robert K. Rude, Lise Binderup, Milan Uskokovic, H. Phillip Koeffler

Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III).

Elin M. Hennig, Zhenhe Suo, Steinar Thoresen, Ruth Holm, Stener Kvinnsland, Jahn M. Nesland

Effect of fenretinide on bone mineral density and metabolism in women with early breast cancer

Andrea Decensi, Rosalba Torrisi, Alberto Gozza, Gianluca Severi, Gianfilippo Bertelli, Vincenzo Fontana, Floriana Pensa, Lauro Carozzo, Attilio Traverso, Sabatino Milone, Dario Dini, Alberto Costa

Serum VEGF levels in women with a benign breast tumor or breast cancer

Petri Salven, Vesa Perhoniemi, Heikki Tykkä, Hanna Mäenpää, Heikki Joensuu

The expression of variant exon v7–v8 CD44 antigen in relation to lymphatic metastasis of human breast cancer

Jun Kinoshita, Shunsuke Haga, Tadao Shimizu, Hiroshi Imamura, Osamu Watanabe, Tetsuro Kajiwara

Effect of thermal variables on human breast cancer in cryosurgery

Johnee Rui, Kristine N. Tatsutani, Rajvir Dahiya, Boris Rubinsky

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine